Back to JAZZ
Hennion & Walsh Asset Management, Inc. → JAZZ
Hennion & Walsh Asset Management, Inc. JAZZ Position History
Jazz Pharmaceuticals plc • Healthcare
Quarters held
7
Latest value
$11.7M
Q3 2026
Peak value
$11.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5M |
| Q3 2025 | $788K |
| Q4 2025 | $8.1M |
| Q4 2025 | $328K |
| Q1 2026 | $9.3M |
| Q2 2026 | $11.6M |
| Q3 2026 | $11.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11.7M | 50.6K | — | — |
| Q2 2026 | $11.6M | 48.0K | — | — |
| Q1 2026 | $9.3M | 49.4K | — | — |
| Q4 2025 | $328K | 6.9K | — | — |
| Q4 2025 | $8.1M | 47.5K | — | — |
| Q3 2025 | $788K | 17.7K | — | — |
| Q3 2025 | $5M | 37.9K | — | — |
Other funds holding JAZZ
$926.1M
$878.5M
$733.9M
$719.1M
$634.9M
$481.9M
$481.9M